The Stigmatization of Drug Use as Mechanism of Legitimation of Exclusion

Silveira, Pollyanna Santos da; Tostes, Joanna Gonçalves Andrade de; Wan, Hoi Ting; Ronzani, Telmo Mota; Corrigan, Patrick W.

doi:10.1007/978-3-319-72446-1_2

Cited by 12 publications

(10 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[14] However, MMT patients commonly face self-and externallyimposed stigma, shame, and discrimination due to their opioid use disorder. [12,15] The addictions fi eld is burdened with areas identifi ed for individuals to improve within, contributing to their diminished self-esteem and perceived lack of control. [15] This is frequently compounded by inequitable living conditions, including poverty, social exclusion, and food insecurity.…”

mentioning

confidence: 99%

“…[12,15] The addictions fi eld is burdened with areas identifi ed for individuals to improve within, contributing to their diminished self-esteem and perceived lack of control. [15] This is frequently compounded by inequitable living conditions, including poverty, social exclusion, and food insecurity. [16] High rates of co-occurring mental health issues and bloodborne diseases are also found among this population.…”

mentioning

confidence: 99%

See 1 more Smart Citation

How Companion Animals Support Recovery from Opioid Use Disorder: An Exploratory Study of Patients in a Methadone Maintenance Treatment Program

Kosteniuk¹,

Dell²

2020

aporia

View full text Add to dashboard Cite

The past decade has witnessed increased attention to the benefits of companion animals on human health, though little attention has been paid to the potential to support recovery from a substance use disorder. Amidst an opioid crisis in Canada, studying this overlooked source of support may be beneficial. This study explores how companion animals support the recovery of seven methadone maintenance treatment patients in a Canadian core neighborhood. Through semi-structured interviews and a thematic analysis, the findings demonstrate that individuals’ companion animals support their recovery in four areas of their lives: (i) social, (ii) health and wellbeing, (iii) home, and (iv) purpose and empowerment. These themes were found to align with and expand upon the four dimensions of a Life in Recovery outlined by the Substance Abuse and Mental Health Services Administration. Structuring the paper by the expanded categories, this study introduces how companion animals fulfilled supportive roles that other humans could not or chose not to provide, while the human-animal bond encouraged a strengths-based approach to individuals’ recovery. This helped foster positive self-identity and a perceived choice over individuals’ recovery pathways.

show abstract

mentioning

confidence: 99%

mentioning

confidence: 99%

How Companion Animals Support Recovery from Opioid Use Disorder: An Exploratory Study of Patients in a Methadone Maintenance Treatment Program

Kosteniuk¹,

Dell²

2020

aporia

View full text Add to dashboard Cite

show abstract

“…Another barrier is the stigma related to AUDs, leading to limited acceptability and adherence to treatment [29,40,41]. As in HICs, stigma remains one of the greatest hindrances for substance users to access health services in LMICs.…”

Section: Summary Of Barriers To Alcohol Bi Implementation In Lmicsmentioning

confidence: 99%

“…Stigma associated with alcohol use disorders [29,[40][41][42] Quality of BI implemented [24] Lack of knowledge about available treatments [38] Primary health care providers are not trained, are overburdened with existing responsibilities [31,32,34,36,37] Low help-seeking rates for alcohol use disorders [38,39] Poor structural resources, including training and systems [34,38] Poor sensitisation among primary health care providers [36,37] Lack of financial resources and investment in BIs [31,32,38] Poor policy planning [48,49,66] Page 5 of 14 made to study them in various countries in Latin America. However, evidence from Cochrane reviews highlights a clear need for more evaluative research on BIs in LMICs [16].…”

Section: Demand Side Supply Sidementioning

confidence: 99%

Brief interventions for alcohol use disorders in low- and middle-income countries: barriers and potential solutions

Nadkarni

Bhatia

Bedendo

et al. 2022

Int J Ment Health Syst

View full text Add to dashboard Cite

Global alcohol consumption and harmful use of alcohol is projected to increase in the coming decades, and most of the increase will occur in low- and middle-income countries (LMICs); which calls for cost-effective measures to reduce alcohol exposure in these countries. One such evidence based measure is screening and brief intervention (BI) for alcohol problems. Some of the characteristics of BI make them a particularly appealing choice of interventions in low-resource settings. However, despite evidence of effectiveness, implementation of BI in LMICs is rare. In this paper we discuss barriers to implementation of BI in LMICs, with examples from Latin America and India. Key barriers to implementation of BI in LMICs are the lack of financial and structural resources. Specialized services for alcohol use disorders are limited or non-existent. Hence primary care is often the only possible alternative to implement BI. However, health professionals in such settings generally lack training to deal with these disorders. In our review of BI research in these countries, we find some promising results, primarily in countries from Latin America, but so far there is limited research on effectiveness. Appropriate evaluation of efficacy and effectiveness of BI is undermined by lack of generalisability and methodological limitations. No systematic and scientific efforts to explore the implementation and evaluation of BI in primary and community platforms of care have been published in India. Innovative strategies need to be deployed to overcome supply side barriers related to specialist manpower shortages in LMICs. There is a growing evidence on the effectiveness of non-specialist health workers, including lay counsellors, in delivering frontline psychological interventions for a range of disorders including alcohol use disorders in LMICs. This paper is intended to stimulate discussion among researchers, practitioners and policy-makers in LMICs because increasing access to evidence based care for alcohol use disorders in LMICs would need a concerted effort from all these stakeholders.

show abstract

“…A response to both COVID-19 and drug use involves government, different sectors of the community and health authorities ( WHO Director-General’s opening remarks at the media briefing on COVID-19 on March 5, 2020 ) to implement evidence-based prevention programs as well as engaging different stakeholders for policy coordination ( Volkow, Poznyak, Saxena, Gerra, & UNODC-WHO Informal International Scientific Network, 2017 ). Generally, drug use prohibition and criminalization approaches result in higher stigmatization and discrimination against PWUD ( Boyd & MacPherson, Vancouver Area Network of Drug Users, 2018 ; Santos da Silveira, Andrade de Tostes, Wan, Ronzani, & Corrigan, 2018 ). This approach puts PWUD at a higher risk of viral transmission.…”

Section: Introductionmentioning

confidence: 99%

COVID-19 and Substance Use Disorders as Brain Diseases: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper

Farhoudian

Baldacchino

Clark

et al. 2020

Basic Clin. Neurosci. J.

115

View full text Add to dashboard Cite

Coronavirus Disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).

show abstract

The Stigmatization of Drug Use as Mechanism of Legitimation of Exclusion

Cited by 12 publications

References 43 publications

How Companion Animals Support Recovery from Opioid Use Disorder: An Exploratory Study of Patients in a Methadone Maintenance Treatment Program

How Companion Animals Support Recovery from Opioid Use Disorder: An Exploratory Study of Patients in a Methadone Maintenance Treatment Program

Brief interventions for alcohol use disorders in low- and middle-income countries: barriers and potential solutions

COVID-19 and Substance Use Disorders as Brain Diseases: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper

Contact Info

Product

Resources

About